Director of Learning and Development
Scholar Rock
Director of Learning and Development
Scholar Rock
Biopharmaceutical firm targeting protein growth factors
Scholar Rock is delivering muscle-targeted breakthroughs to transform the treatment of spinal muscular atrophy (SMA) and other rare neuromuscular diseases where muscle atrophy remains a critical unmet need.
As a global leader in myostatin biology, a field focused on proteins that regulate muscle mass, the biopharmaceutical company is named for the visual resemblance of a scholar rock to protein structures. Our commitment to unlock fundamentally different treatment approaches is powered by broad application of a proprietary platform, which has developed novel monoclonal antibodies to modulate protein growth factors with extraordinary selectivity. Scholar Rock works every day to create new possibilities for patients through its highly innovative anti-myostatin program, including opportunities in additional rare neuromuscular diseases. Learn more about our neuromuscular franchise at ScholarRock.com and follow @ScholarRock on X and on LinkedIn.
We are seeking a strategic and results-driven Director, Learning & Development – EMEA to lead the development and execution of learning initiatives across EMEA markets.
This role will focus on strengthening organizational capabilities across three key pillars: Clinical Acumen, Business Acumen, and Leadership & Soft Skills, ensuring employees have the knowledge, skills, and confidence to drive business performance.
The Director will partner closely with regional leadership and global cross-functional teams to deliver a consistent global learning strategy while addressing local market needs.
Clinical Acumen & Scientific Excellence
Business Acumen & Commercial Excellence
Leadership Development & Soft Skills
Global Alignment & Learning Effectiveness
Medical, Legal & Compliance Governance
In Europe, learning operates within a highly regulated framework. The Director will establish and run a structured governance and operating model with Medical Affairs and the Information Officer / Scientific Service on one side, and Legal & Compliance on the other. This model ensures that all scientific and medical training content is accurate, balanced and approved through the appropriate channels, and that all learning, especially for customer-facing roles, meets applicable legal, regulatory and industry code requirements.
Success Measures
Biopharmaceutical firm targeting protein growth factors
Scholar Rock develops biopharmaceutical therapies by targeting protein growth factors to treat diverse diseases. Its work hinges on a proprietary drug discovery platform that identifies ways to modulate these growth factors, enabling creation of novel therapeutic solutions. The company advances its programs through research and development, and collaborates with other biopharmaceutical companies and research institutions, earning revenue via licensing agreements, milestone payments, and eventual product sales. Scholar Rock differentiates itself by focusing on protein growth factors and pursuing targets and indications that have been historically overlooked, with a strong emphasis on partnerships and patient-centric approaches. The overall goal is to deliver safe and effective therapies that improve patient outcomes by precisely modulating growth factor pathways through collaborative science.
Explore more opportunities at Scholar Rock